SCHEMBL7345772

SCHEMBL7345772

CSc1cccc(CC(NC(=O)CNC(=O)c2cccc(NC=NN)c2)C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR132 Q9UNW8 1/20 0.39
CTSV O60911 1/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
ITGB1 P05556 6/20 0.39
ITGB3 P05106 5/20 0.39
ITGAV P06756 5/20 0.39
ITGA5 P08648 5/20 0.39
MDM2 Q00987 4/20 0.39
ITGA2B P08514 1/20 0.38
ITGB5 P18084 1/20 0.38
GPR139 Q6DWJ6 6/20 0.38
MDM4 O15151 1/20 0.38
MAPT P10636 1/20 0.38
FOLH1 Q04609 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6775970 0.89 GPR132 (0.49) GPR132ITGB1ITGB3ITGAVITGA5
SCHEMBL7838300 0.87 ITGB3 (0.51) GPR132CTSVCTSLCTSBCTSS
SCHEMBL6772224 0.87 CTSV (0.50) GPR132CTSVCTSLCTSBCTSS
SCHEMBL6773776 0.86 CTSB (0.43) GPR132CTSVCTSLCTSBCTSS
SCHEMBL7340682 0.86 ALDH1A1 (0.47) GPR132CTSVCTSLCTSBCTSS
SCHEMBL6778268 0.85 GPR139 (0.44) GPR132CTSVCTSLCTSBCTSS
SCHEMBL3051751 0.84 GPR139 (0.44) GPR132CTSVCTSLCTSBCTSS
SCHEMBL7823171 0.84 ITGB3 (0.50) GPR132ITGB1ITGB3ITGAVITGA5
SCHEMBL7339636 0.84 GPR132 (0.50) GPR132GPR139ALDH1A1KMT2A
SCHEMBL6778084 0.84 GPR139 (0.45) GPR132CTSVCTSLCTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP claimed
US-6028223-A AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS G. D. SEARLE & CO. (US) 2000-02-22 US claimed
EP-0850221-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1998-07-01 EP claimed
WO-1997008145-A1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-03-06 WO claimed